Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Orange Belgium invites investors and analysts to participate in its H1 2025 results online web conference and audio conference call on 24 July 2025
-
Murano Announces Enhancements to its Core Strategy with Bitcoin (BTC) Treasury Initiative Following Execution of Up to $500 Million Standby Equity Purchase Agreement (SEPA)
-
ASML reports transactions under its current share buyback program
-
Artelo Biosciences Announces Positive Preclinical Efficacy with ART12.11 in Stress-Induced Depression Model
-
Medicines for Poland Announces: Without pharmaceutical factories Europe will lose any war
-
Form 8.3 - Marlowe plc - Octopus Investments
-
Camouflaged Cayenne Electric demonstrates performance and practicality
-
HUB Cyber Security (Nasdaq: HUBC) Appoints Aviv Eyal to Lead AI-Native Digital Asset Infrastructure Division
-
Infortar's subsidiary completed the acquisition of shares in Estonia Farmid OÜ
-
Centerra Gold Provides Notice of Second Quarter 2025 Results and Conference Call
-
FTI Consulting Report: An Endgame for the Epic E-Commerce Era Is Within Sight
-
Jasper Therapeutics Reports Clinical Data Update from Briquilimab Studies in Chronic Spontaneous Urticaria
-
Copper Road announces the appointment of a new CEO
-
Unisync announces the retirement of Douglas F. Good as CEO
-
Almaden Provides Update on Arbitration Procedure with Mexico
-
AIFU Announces $31.6 Million Non-Brokered Private Placement
-
FuelCell Energy CEO Jason Few Applauds “One Big Beautiful Bill Act” as Catalyst for U.S. Clean Energy Leadership
-
Osisko Development Announces Positive Bulk Tonnage Ore Sorting Results for the Cariboo Gold Project
-
Yiviva Presents Phase 2b Results for YIV-906 in Combination with Sorafenib in Advanced Hepatocellular Carcinoma at ASCO and ESMO GI 2025
-
Quipt Home Medical Acquires Healthcare System Owned Medical Equipment Provider with $6.6 Million in Revenue, and Signs Preferred Provider Agreement Covering 20 Hospitals Across 4 States
-
Onco360 Has Been Selected as a National Specialty Pharmacy for Augtyro™ (repotrectinib)
-
Kvika banki hf.: Transaction in relation to a share buy-back programme
-
At the Yacht Club de Monaco nautical prototypes and laboratories come together for the zero emissions goal
-
WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY (a public company incorporated with limited liability in Ireland) WISDOMTREE S&P 500 3X DAILY SHORT SECURITIES ISIN: IE00B8K7KM88
-
OR Royalties Announces Preliminary Q2 2025 GEO Deliveries Along with Record Quarterly Revenue & Cash Margin
-
OR Royalties Announces Preliminary Q2 2025 GEO Deliveries Along with Record Quarterly Revenue & Cash Margin
-
IREN June 2025 Monthly Update
-
Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Adv
-
The Joint Corp. Closes Sale of 31 Corporate Clinics in Arizona and New Mexico and Acquires Regional Developer Rights in the Northwest Region
-
New Business Book Unveils 17 Proven Rules to Save, Sustain, and Scale Struggling Companies
-
Lightchain AI Opens Bonus Round Following $20.9M Raised Across 15 Presale Stages
-
BioCryst Appoints Babar Ghias Chief Financial Officer and Head of Corporate Development
-
CORRECTION – Dr. Anosh Ahmed Announces Major Expansion of COVID Testing Contracts Across U.S. and International Markets
-
Orchard Therapeutics Announces Last Patient Treated in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
-
Boehringer Ingelheim initiates Phase II study of BI 1815368, a potential first-in-class oral treatment for diabetic macular edema
-
Aya Gold & Silver Reports High-Grade Boumadine Exploration Results, Expands Imariren to 1km and Identifies New High-Grade Asirem Zone to the West
-
Lancaster Strengthens Gold Portfolio with Completion of Lake Cargelligo Acquisition
-
Carlton Announces Results of Annual and Special Meeting of Shareholders
-
Western Financial Group Wins 2025 Canadian Business Excellence Award
-
VitalHub Announces Acquisition of Novari Health Inc.
-
BeyondSpring Publishes Human Clinical Study in Med (Cell Press) Showing Plinabulin-Driven Dendritic Cell Maturation and Tumor Response After Prior Checkpoint Inhibitor Failure
-
Axsome Therapeutics to Showcase Its Innovative CNS Pipeline at Upcoming Frontiers in Brain Health R&D Day in New York City on July 21
-
Inventus Reports 4.10 gpt Gold and 1.78 Metre Average in 30 Drill Holes Within 6 Metres of Surface at the 10,000-Tonne Trench 1 Bulk Sample Site
-
La Caisse and Fondaction invest $250 million by way of a subordinated loan to Boralex
-
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
-
Tonix Pharmaceuticals Announces Oral Presentation on Mpox and Smallpox vaccine candidate TNX-801 at the Vaccine Congress 2025
-
Unicycive Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference
-
Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia
-
European Medicines Agency Grants Bexobrutideg (NX-5948) Orphan Drug Designation for the Treatment of Lymphoplasmacytic Lymphoma, also Known as Waldenström Macroglobulinemia
-
Heidmar Maritime Holdings Corp. Acquires Its First Vessel and Establishes Foothold in Container Shipping
